Letter from Willey and Biviano Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
From Department of Neurology, Columbia University, New York, NY (J.Z.W.); and Division of Cardiology, Cardiac Electrophysiology Service, Department of Medicine, Columbia University, New York, NY (A.B.).
Joshua Z
JZ
Willey
From Department of Neurology, Columbia University, New York, NY (J.Z.W.); and Division of Cardiology, Cardiac Electrophysiology Service, Department of Medicine, Columbia University, New York, NY (A.B.).
Angelo
A
Biviano
D000638:Amiodarone / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents; D001281:Atrial Fibrillation; D017115:Catheter Ablation; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone